Articles by Disease (Non Hodgkin's Lymphoma)

Recombinant Human Polyclonal Antibodies: A New Class of Therapeutic Antibodies Against Viral Infections

Journal: Current Pharmaceutical Design
Volume: 12
Page: 2007-2015
Author(s): Søren Bregenholt, Allan Jensen, Johan Lantto, Sara Hyldig and John S. Haurum

Human T-Cell Leukemia Virus Type 1: Transition from Latent Infection to Pathogenic Progression and Implications for Molecular Therapy

Journal: Current Cancer Therapy Reviews
Volume: 2
Page: 101-113
Author(s): Yulia Tabakin-Fix, Inbal Azran-Shaish, Yana Schavinsky-Khrapunsky, Rachel Chamias, Lilach Gohari, Mahmoud Huleihel, Min Li-Weber and Mordechai Aboud

Treatment Strategies for Multiple Myeloma in the Age of Novel Therapies

Journal: Current Cancer Therapy Reviews
Volume: 2
Page: 169-183
Author(s): Laurence Catley and Kenneth C. Anderson

IL-2 Receptor Targeted Immunomodulatory Biologics: The Past, Present, and Future

Journal: Current Immunology Reviews (Discontinued)
Volume: 2
Page: 187-208
Author(s): Deanna D.H. Franke and Haval Shirwan

Regulatory T Cells in Cancer Biology: A Possible New Target for Biochemical Therapies

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 6
Page: 509-513
Author(s): Dominik Wolf, Holger Rumpold and Anna-Maria Wolf

Signal Transduction Therapy Targeting Apoptosis Pathways in Cancers

Journal: Current Signal Transduction Therapy
Volume: 1
Page: 179-190
Author(s): Simone Fulda and Klaus-Michael Debatin

Antisense Oligodeoxynucleotide Therapy for Prostate Cancer Targeting Antiapoptotic Genes Involved in the Mechanism Mediating Progression to Androgen Independence

Journal: Current Signal Transduction Therapy
Volume: 1
Page: 219-226
Author(s): Hideaki Miyake, Isao Hara, Masato Fujisawa and Martin E. Gleave